Assertio
Manufacturing · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
100 S Saunders Rd Ste Ste 300, Lake Fore...Phone Number
(224) 419-7106Website
www.assertiotx.comRevenue
$118.7 MillionStock Symbol
ASRTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Assertio
Founded in 1995, Assertio is a commercial pharmaceutical company that develops and markets branded prescription medications. The company specializes in neurology, inflammation, and pain management products. Assertio has expanded its portfolio through strategic acquisitions, licensing agreements, and mergers. The company operates across multiple global regions including North America, Europe, and Asia. Assertio focuses on delivering differentiated pharmaceutical products to patients while pursuing growth opportunities across various therapeutic areas.Explore more
Assertio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Assertio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Assertio launches new products
Congratulate Masked Content for being promoted to Masked Content at Assertio
Funding: Get notified immidiatlly once Assertio has new funding data
Check out if Assertio is spiking on competitors!
Earning: See what the market has to say on Assertio recently announced quarterly report
Check if Assertio has recently received funding, and reach out quickly before it becomes old news!
Assertio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Assertio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Assertio as Masked Content
Find 3 more new buyers
Compare Similar Companies to Assertio
Compare insights from companies similar to Assertio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Assertio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Assertio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Assertio.
Assertio financials insights
Gather financial insights about Assertio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1997
Stock Offering
$7.2M
2021
Share Placement
$34.3M
Assertio Tech Stack
A closer look at the technologies used by Assertio
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Divestiture
Divestitures, Pharmaceuticals, Corporate Strategy, Finance
Assertio News & Media
Assertio: $166.4 Million Acquisition By Zydus Worldwide DMCC Announced - Pulse 2.0
Assertio Holdings announced that it has entered into a definitive agreement to be acquired by Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Limited, in an all-cash transaction valued at approximately $166.4 million.Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, May 13, 2026 /PRNewswire/ -- Ademi LLP is investigating Assertio (NASDAQ: ASRT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Zydus. Click here to learn how to join our investigation and obtain additional...Garda to acquire Assertio (NASDAQ: ASRT) for $21.80 cash per share - Stock Titan
Garda raised its all-cash offer for Assertio to $21.80 per share, a 63.1% premium to the unaffected price, backed by $22.2M equity and $130M debt commitments.ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Assertio
Sign Up For FreeTo access detailed company insights
Founded in 1995, Assertio is a commercial pharmaceutical company that develops and markets branded prescription medications. The company specializes in neurology, inflammation, and pain management products. Assertio has expanded its portfolio through strategic acquisitions, licensing agreements, and mergers. The company operates across multiple glo... Read More
